Skip to main content
Clinical Trials/IRCT20180205038617N1
IRCT20180205038617N1CompletedPhase 3

Evaluation the effect of topical prednisolon acetate 1% on the pupillary diameter and ocular pain after uncomplicated cataract surgery in diabetic and non diabetic patients

Mashhad University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40 years to no limit (—)
Sex
All

Inclusion Criteria

  • In non- diabetic group: Patients over 40 years old with cortical cataract, posterior subcapsular or grade 2 to 3 nuclear sclerosis that have indication of phacoemulsification surgery with general anesthesia
  • In diabetic group: Patients over 40 years old with cortical cataract, posterior subcapsular or grade 2 to 3 nuclear sclerosis that have pseudoexfuliation or non proliferative diabetic retinopathy and have indication of phacoemulsification surgery with general anesthesia

Exclusion Criteria

  • History of previous intraocular surgery
  • collagen vascular disease
  • history of previous or current topical steroids, alphablocker or antiglaucoma medication
  • history of previous or current systemic steroid use
  • history of uveitis
  • mature cataract

Investigators

Similar Trials